For those struggling with musculoskeletal disorders and autoimmune diseases, Hospital for Special Surgery (HSS) in New York City is a godsend. The specialty hospital, nationally ranked No. 2 in orthopedics, No. 3 in rheumatology and No. 24 in neurology by U.S. News & World Report’s “America’s Best Hospitals” issue and offers patients a hope with industry-leading patient care and medical innovation. Hospital for Special Surgery prides itself on better diagnosing and the use of specialized use of arthroscopic surgery to assist patients with their mobility. For example, HSS were pioneers of the first artificial knee –an example of how they are helping patients gain access to new therapies for their treatment of orthopedic conditions and rheumatic diseases.

HSS is continually working to bring new innovations to their medical field. In September, they announced their new Center for Hip Pain and Preservation, which provides patients suffering from hip pain with effective treatment and accurate diagnoses. The Center for Hip Pain and Preservation works to slow or even reverse the progression of degenerative hip disease, allowing patients to live their life normally and avoid serious surgeries. The Center boasts the expertise of many of the top health care professionals in the nation, including top radiologists, physical therapists, and musculoskeletal experts all under one roof. In October of this year, HSS found that patiens suffering from femoroacetebular impingement (FAI) may benefit from hip arthroscopy.

The Center is just another example of how HSS is always striving to be at the top of the hospital game. Some current issues that scientists at HSS are working on include bone biology, bone healing and soft tissue repair. In addition, scientists at HSS are continually studying autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus.

With uncompromising quality in diagnoses, treatment, and research, HSS has set the bar for specialty hospitals around the nation. HSS provides patients suffering from debilitating diseases with improved mobility and overall quality of life with their stellar health care. One can say with certainty that HSS will continue to grow and help patients, with no end in sight.

Monday 16 November 2009